Spasmodic Dysphonia in Multiple Sclerosis Treatment With Botulin Toxin A: A Pilot Study. Di Stadio A, Bernitsas E, Restivo DA, Alfonsi E, et al. J Voice 2019;33:550-553.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Di Stadio A, Bernitsas E, Restivo DA, Alfonsi E, et al. Spasmodic Dysphonia in Multiple Sclerosis Treatment With Botulin Toxin A: A Pilot Study. J Voice 2019;33:550-553.
PMID: 29650331